--------------------------------------------------------------------------------------------------------------------- NUMBER OF SHARES PERCENT OF ALL NAME OWNED OUTSTANDING SHARES(1) --------------------------------------------------------------------------------------------------------------------- China Merchants DiChain Investment Holdings Limited 20,772,330 45.0% Units 3207-08, West Tower, Shun Tak Centre 168-200 Connaught Road Central, Hong Kong --------------------------------------------------------------------------------------------------------------------- Anmer Capital Limited 6,407,110 13.9% 172 Kaixuan Road, Jianggan District, Hangzhou Zhejiang Province, The People's Republic of China --------------------------------------------------------------------------------------------------------------------- Good Achieve Investments Limited 3,005,064 6.5% Room 4905, Office Tower, Convention Plaza 1 Harbour Road, Wanchai, Hong Kong --------------------------------------------------------------------------------------------------------------------- Aaron ZHU Xiaojun(2) 20,772,330 45.0% --------------------------------------------------------------------------------------------------------------------- Dr. FAN Di(2) 20,772,330 45.0% --------------------------------------------------------------------------------------------------------------------- KWOK Yam Sheung 0 -- --------------------------------------------------------------------------------------------------------------------- Officers and Directors as a group (3 persons) 20,772,330 45.0% --------------------------------------------------------------------------------------------------------------------- ------------------ 1 The percentages shown are based on 46,160,733 shares, being the total of the issued and outstanding shares of the registrant as of April 22, 2004 and giving effect to the issuance of 45,400,000 shares upon completion of the acquisition of Zheda Pharmacy. 2 China Merchants DiChain Investment Holdings Limited is the record owner of these 20,772,330 shares of common stock of the registrant. Dr. FAN Di, an officer and director of the registrant, is also a director of China Merchants 2 DiChain Investment Holdings Limited and both Dr. FAN Di and Aaron ZHU Xiaojun, an officer and director of the registrant, are directors of the sole controlling shareholder of China Merchants DiChain Investment Holdings Limited. Accordingly, they are deemed to be beneficial owners of these shares.UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): September 14, 2007

China Pharmaceuticals International Corporation

(Exact name of Registrant as specified in its charter)

British Virgin Islands

(Jurisdiction of incorporation or organization)

000-28879

(Commission File Number)

98-0348508

(IRS Employer Identification No.)

Suite A, 22/F, Noble Center, 3^rd Fu Zhong Road, Fu Tian District,

518026, Shen Zhen, Guang Dong Province, China

(Address of principal executive offices)

This Current Report on Form 8-K is filed by China Pharmaceuticals International, a British Virgin Islands corporation (the “Registrant”), in connection with the items set forth below.

ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

On August 1, 2007, Li Xinggui resigned as a member of the Board of Directors of the Company. There was no disagreement or dispute between Mr. Xinggui and the Company which led to his resignations.

On August 1, 2007, TAI Ching Nam resigned as a Excutive Vice President of the Company. There was no disagreement or dispute between Mr. Nam and the Company which led to his resignations.

On August 1, 2007 Ms. Fu Li was appointed as a director of the Company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CHINA PHARMACEUTICALS INTERNATIONAL CORPORATION

Date: September 14, 2007	By:	/s/ FAN Di
		FAN Di President (Chief Executive Officer), Acting Financial Officer

Filing Compare · CHINA HELI RESOURCE RENEWABLE INC